Status:
COMPLETED
Using Continuous Glucose Monitoring to Detect and Intervene on Maintenance Factors for Trans-diagnostic Binge Eating Pathology
Lead Sponsor:
Drexel University
Conditions:
Bulimia Nervosa
Binge Eating
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The current study will be one of the first to develop and test a passive data collection technique to detect both meal consumption and disordered eating symptoms in patients with clinically significan...
Eligibility Criteria
Inclusion
- Are 18 to 65 years old
- Experience clinically significant binge eating (defined as 12 or more objectively large binge eating episodes in the past 3 months)
- Engage in clinically significant dietary restriction (define as \>1 standard deviation above community norms on the Eating Disorder Examination Dietary Restraint Subscale)
- Have a BMI above 18.5
- Are able to give consent
Exclusion
- Are unable to fluently speak, write and read English
- Are receiving treatment for an eating disorder
- Require immediate treatment for medical complications as a result of eating disorder symptoms
- Have a mental handicap, or are experiencing other severe psychopathology that would limit the participants' ability to comply with the demands of the current study (e.g. severe depression with suicidal intent, active psychotic disorder)
- Have diabetes
- Are pregnant or planning to become pregnant within the next year
Key Trial Info
Start Date :
July 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04126694
Start Date
July 6 2020
End Date
August 1 2021
Last Update
September 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Drexel University
Philadelphia, Pennsylvania, United States, 19104